<- Go Home

Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.

Market Cap

EUR 27.2B

Volume

955.6K

Cash and Equivalents

EUR 2.4B

EBITDA

EUR 2.5B

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 5.3B

Profit Margin

23.84%

52 Week High

EUR 50.74

52 Week Low

EUR 31.60

Dividend

2.07%

Price / Book Value

1.46

Price / Earnings

24.86

Price / Tangible Book Value

14.67

Enterprise Value

EUR 39.0B

Enterprise Value / EBITDA

13.54

Operating Income

EUR 1.8B

Return on Equity

5.89%

Return on Assets

2.61

Cash and Short Term Investments

EUR 2.4B

Debt

EUR 13.5B

Equity

EUR 19.3B

Revenue

EUR 22.4B

Unlevered FCF

EUR 1.7B

Sector

Health Care Providers and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches